ISPC

iSpecimen Inc

0.7763

Nov 09 • 3:49 PM ET -0.0379 (-4.65%)

Healthcare Diagnostics & Research USA Nano NASD

Nov 05, 4:41 PMiSpecimen completes $4.5 million acquisition of Foldlab AI protein-discovery and disease-trend prediction products

Peers: AZTA CRL CSBR IQV BDSX PRPO DGX SHC CCEL FTRE

Scroll to Statements

Index	-
Market Cap	1.95M
Enterprise Value	-2.22M
Income	-11.42M
Sales	0.47M
Book/sh	1.14
Cash/sh	1.75
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	7
IPO	Jun 17, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	4.16
P/B	0.68
P/C	0.44
P/FCF	-
EV/EBITDA	-
EV/Sales	-4.71
Quick Ratio	0.82
Current Ratio	0.82
Debt/Eq	0.14
LT Debt/Eq	0.10
Option/Short	No / Yes

EPS (ttm)	-50.28
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	53.84% 30.62%
Sales past 3/5Y	-42.97% -25.10%
EPS Y/Y TTM	86.78%
Sales Y/Y TTM	-92.11%
EPS Q/Q	94.17%
Sales Q/Q	-78.69%
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	0.00%
Insider Trans	-
Inst Own	3.38%
Inst Trans	379.11%
ROA	-170.10%
ROE	-968.47%
ROIC	-596.00%
Gross Margin	-355.95%
Oper. Margin	-2020.04%
Profit Margin	-2449.04%
SMA20	-11.41%
SMA50	-31.60%
SMA200	-82.51%
Trades

Shs Outstand	2.52M
Shs Float	2.52M
Short Float	6.30%
Short Ratio	0.22
Short Interest	0.16M
52W High	27.44 -97.17%
52W Low	0.75 3.09%
Volatility	13.67% 9.89%
ATR (14)	0.09
RSI (14)	31.88
Beta	1.73
Rel Volume	0.07
Avg Volume	721.01K
Volume	51,942

Perf Week	-6.73%
Perf Month	-31.30%
Perf Quarter	-65.95%
Perf Half Y	-84.63%
Perf YTD	-92.54%
Perf Year	-96.96%
Perf 3Y	-99.82%
Perf 5Y	-99.98%
Perf 10Y	-
Recom	1.00
Target Price	2400.00
Prev Close	0.81
Price	0.78
Change %	-4.65%

Nov-05-26 04:05PM	iSpecimen Expands Into AI-Powered Drug Discovery and Disease Trend Monitoring With Acquisition of Foldlab AI Products (Newsfile Corp.)
Oct-29-26 04:10PM	iSpecimen Offers Next-Day Healthy Donor Blood and Launches Development of AI Agent (Newsfile) -9.35%
Sep-29-26 08:05AM	iSpecimen Supports Hospital Validation of New Chemistry Analyzer (Newsfile Corp.)
Aug-20-26 04:05PM	iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks (GlobeNewswire) -25.55%
Aug-07-26 04:30PM	iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire)
08:30AM	Loading…
Aug-06-26 08:30AM	iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire) +14.58%
May-08-26 09:04PM	iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement (GlobeNewswire)
Apr-24-26 09:00AM	iSpecimen Announces 1-for-40 Reverse Stock Split (Newsfile) -19.61%
Apr-17-26 10:30AM	BC-Most Active Stocks (Associated Press) +17.17%
Apr-13-26 10:30AM	BC-Most Active Stocks (Associated Press) -9.45%
Apr-10-26 10:30AM	BC-Most Active Stocks (Associated Press)
Apr-09-26 04:05PM	iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time (Newsfile) -10.34%
Mar-16-26 07:47AM	iSpecimen Achieves Rapid Procurement Milestone for Influenza Research (Newsfile) -30.87%
Mar-12-26 04:05PM	iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching (Newsfile) -6.67% +26.96%
Feb-06-26 09:30AM	iSpecimen Announces Milestone 2: System Integration and Marketplace Activation Complete (Newsfile)
08:20AM	Loading…
08:20AM	iSpecimen Achieves Rapid Procurement Milestone for Influenza Research (Newsfile)
Dec-30-25 02:37PM	iSpecimen Inc. Announces Pricing of ~$5.5 Million Private Placement (GlobeNewswire) -13.15%
Sep-05-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +27.42%
Sep-04-25 04:05PM	iSpecimen Approached by Crypto Currency Companies for $200 Million Treasury Discussions (Newsfile)
Aug-21-25 08:00AM	iSpecimen Announces Completion of Milestone 1 in Digital Transformation Journey with Salestack Platform (Newsfile) -29.77%
Aug-14-25 12:51PM	iSpecimen to Establish $200M Corporate Treasury Built Around Solana Cryptocurrency with BlockArrow (Newsfile)
Aug-07-25 04:05PM	iSpecimen to Establish $200M Corporate Treasury Built Around Solana Cryptocurrency with BlockArrow (Newsfile) +6.51% -28.89%
Aug-04-25 06:45PM	iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market (GlobeNewswire)
Jul-31-25 04:06PM	iSpecimen Inc. Announces Pricing of Approximately $1.75 Million Private Placement Priced At-the-Market (GlobeNewswire) +18.55%
Jul-28-25 04:35PM	Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering (GlobeNewswire)
04:30PM	Correction: iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering (GlobeNewswire)
Jul-25-25 01:53PM	iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering (GlobeNewswire)
Jul-24-25 08:30AM	iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering (GlobeNewswire)
Jan-16-25 04:01PM	iSpecimen Secures Suppliers for COVID-style hMPV Outbreak (Newsfile) +7.95% -16.84%
Dec-20-24 08:30AM	iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens (Newsfile)
07:30AM	Loading…
Dec-13-24 07:30AM	iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers (Newsfile) -15.36%
Dec-12-24 05:11PM	iSpecimen Appoints Robert Lim as CEO and Director (Newsfile)
Nov-08-24 07:30AM	iSpecimen Named Top Competitor in $4.4 Billion USD Market (Newsfile)
Nov-07-24 07:30AM	iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually (GlobeNewswire) +11.26%
07:00AM	iSpecimen Reports Third Quarter 2024 Results (GlobeNewswire)
Oct-31-24 03:07PM	iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire)
Oct-30-24 08:30AM	iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire)
Sep-26-24 07:30AM	iSpecimen Secures $1 Million Loan; Appoints Three New Board Members (GlobeNewswire)
Sep-16-24 09:38AM	Upcoming Stock Splits This Week (September 16 to September 20) Stay Invested (TipRanks) +15.92%
Sep-11-24 04:30PM	iSpecimen Announces 1-for-20 Reverse Stock Split (GlobeNewswire) -23.17%
Aug-06-24 07:30AM	iSpecimen Reports Second Quarter 2024 Results (GlobeNewswire)
Jul-25-24 04:05PM	iSpecimen to Report Second Quarter 2024 Results on August 6, 2024 (GlobeNewswire)
Jun-06-24 07:38AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace) +25.61%
May-13-24 09:53AM	iSpecimen Inc. (NASDAQ:ISPC) Q1 2024 Earnings Call Transcript (Insider Monkey) -6.13%
May-08-24 03:19AM	iSpecimen Inc (ISPC) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and ... (GuruFocus.com) -6.72%
May-07-24 07:30AM	iSpecimen Reports First Quarter 2024 Results (GlobeNewswire) +7.75%
Apr-25-24 08:00AM	iSpecimen to Report First Quarter 2024 Financial Results on May 7, 2024 (GlobeNewswire)
Mar-15-24 10:48AM	iSpecimen Inc. (NASDAQ:ISPC) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-14-24 08:00AM	iSpecimen Reports Full Year 2023 Results (GlobeNewswire) -21.76%
Mar-12-24 07:07PM	iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call (GlobeNewswire) +12.20%
Mar-05-24 04:30PM	iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024 (GlobeNewswire)
Jan-23-24 07:30AM	iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research (GlobeNewswire)
Jan-22-24 04:15PM	Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET (GlobeNewswire)
Jan-18-24 08:11AM	iSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024 (GlobeNewswire)
Dec-07-23 07:30AM	iSpecimen Strengthens Global Oncology Biospecimen Offering (GlobeNewswire) -6.70%
Nov-05-23 11:01AM	iSpecimen Inc. (NASDAQ:ISPC) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-02-23 07:30AM	iSpecimen Reports Third Quarter 2023 Financial and Operating Results (GlobeNewswire) -5.57%
Oct-26-23 07:30AM	iSpecimen Expands Proprietary Provider Network to Help Advance Infectious Disease Research (GlobeNewswire)
Oct-23-23 07:30AM	iSpecimen Preannounces Third Quarter 2023 Revenue Increase of 60-70% Sequentially (GlobeNewswire)
Sep-28-23 07:30AM	iSpecimen Launches Next-Day Quote Service for Medical Researchers and Biospecimen Providers (GlobeNewswire)
Sep-16-23 01:01AM	Insider Buying: Benjamin Bielak Acquires 18,000 Shares of iSpecimen Inc (GuruFocus.com)
Sep-13-23 07:30AM	iSpecimen Expands Provider Network to Enhance Support for Womens Health Research (GlobeNewswire)
Sep-07-23 02:07PM	Biotech services company iSpecimen company lays off one-quarter of its staff (American City Business Journals)
Sep-06-23 04:05PM	iSpecimen Announces Organizational Changes to Enhance Operational Efficiencies and Drive Profitability (GlobeNewswire)
Aug-30-23 07:30AM	iSpecimen Launches New Virtual Cancer Sequencing Procurement Program (GlobeNewswire)
Aug-16-23 07:30AM	iSpecimen Enhances Proprietary Marketplace Platform to Streamline Biospecimen Matchmaking for Researchers and Providers (GlobeNewswire)
Aug-09-23 07:30AM	iSpecimen Introduces New Marketplace Functionality to Streamline Access to Clinical Remnant Samples for Researchers (GlobeNewswire)
Aug-07-23 06:02AM	One iSpecimen Inc. (NASDAQ:ISPC) Analyst Just Made A Major Cut To Next Year's Estimates (Simply Wall St.) -5.97%
Aug-02-23 07:00AM	iSpecimen Reports Second Quarter 2023 Financial and Operating Results (GlobeNewswire) -9.93%
Jul-25-23 07:30AM	iSpecimen to Report Second Quarter 2023 Results on August 2, 2023 (GlobeNewswire)
Jul-06-23 07:30AM	Thirteen New Biospecimen Suppliers Added to iSpecimens Proprietary Provider Network (GlobeNewswire)
May-23-23 07:30AM	iSpecimen to Participate in Maxims Healthcare IT Virtual Conference on June 1, 2023 (GlobeNewswire) +10.99%
May-04-23 07:00AM	iSpecimen Reports First Quarter 2023 Results (GlobeNewswire)
Apr-24-23 07:30AM	iSpecimen to Participate in the Aegis Virtual Conference on May 4, 2023 (GlobeNewswire)
Apr-20-23 07:00AM	iSpecimen to Report First Quarter 2023 Results on May 4, 2023 (GlobeNewswire) +11.00%
Apr-18-23 06:26AM	Market Might Still Lack Some Conviction On iSpecimen Inc. (NASDAQ:ISPC) Even After 33% Share Price Boost (Simply Wall St.)
Mar-17-23 04:56AM	iSpecimen Inc. (NASDAQ:ISPC) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-14-23 10:21PM	Q4 2022 iSpecimen Inc Earnings Call (Thomson Reuters StreetEvents)
07:00AM	iSpecimen Reports Full Year 2022 Results (GlobeNewswire)
Mar-02-23 07:00AM	iSpecimen Named to Fast Companys Worlds Most Innovative Companies Annual List for 2023 (GlobeNewswire)
Feb-28-23 04:02PM	iSpecimen to Report Fourth Quarter and Full Year 2022 Results on March 14, 2023 (GlobeNewswire) +7.24% -5.52%
Feb-08-23 07:30AM	iSpecimen Expands Biospecimen Provider Network (GlobeNewswire)
Jan-24-23 11:00AM	Maxim Group LLC to Host the Healthcare IT Virtual Conference on Wednesday, January 25th at 8:15 A.M. ET (GlobeNewswire)
07:30AM	iSpecimen Appoints Eric Langlois as Chief Revenue Officer (GlobeNewswire)
Jan-23-23 07:30AM	iSpecimen to Participate in the Sequire Biotechnology Conference on February 2, 2023 (GlobeNewswire)
Jan-19-23 07:30AM	iSpecimen to Participate in Maxims Healthcare IT Virtual Conference on January 25, 2023 (GlobeNewswire)
Jan-10-23 01:11PM	iSpecimen Names Tracy Curley as Chief Executive Officer (GlobeNewswire) +6.25%
Dec-05-22 07:30AM	iSpecimen Appoints Joseph J. Basile to Board of Directors (GlobeNewswire)
Nov-08-22 07:00AM	iSpecimen Reports Third Quarter 2022 Financial and Operating Results (GlobeNewswire)
Oct-27-22 08:43AM	Multiple insiders bought iSpecimen Inc. (NASDAQ:ISPC) stock earlier this year, a positive sign for shareholders (Simply Wall St.)
07:30AM	iSpecimen Launches New Open Feasibilities Dashboard on the iSpecimen Marketplace Platform to Enhance Biospecimen Fulfillment for Global Partner Network (GlobeNewswire)
Oct-25-22 07:30AM	iSpecimen to Report Third Quarter 2022 Results on November 8, 2022 (GlobeNewswire) +5.23%
Oct-18-22 07:30AM	iSpecimen to Participate in the ThinkEquity Conference on October 26, 2022 (Newsfile) +10.90%
Oct-04-22 07:30AM	iSpecimen Launches Marketplace Onsite Program to Optimize Biospecimen Procurement Process for Sample Providers (GlobeNewswire)
Sep-29-22 05:25AM	The Petri Dish: iSpecimen's founding CEO, longtime COO depart (American City Business Journals) -9.78%
Sep-22-22 04:15PM	iSpecimen Names Chief Financial Officer, Tracy Curley, Interim CEO (GlobeNewswire) +26.49% +7.85%
Aug-31-22 07:30AM	iSpecimen to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022 (GlobeNewswire)
Aug-07-22 08:17AM	iSpecimen Inc. (NASDAQ:ISPC) Consensus Forecasts Have Become A Little Darker Since Its Latest Report (Simply Wall St.)
Aug-04-22 07:00AM	iSpecimen Reports Second Quarter 2022 Financial and Operating Results (GlobeNewswire) -13.95%
Jul-21-22 07:30AM	iSpecimen to Report Second Quarter 2022 Results on August 4, 2022 (GlobeNewswire)

Show Previous News

iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in 2009 and is headquartered in Woburn, MA.

Chief Financial OfficerMr. Yuying Liang

Chief Executive OfficerMr. Shahin Behroyan

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ISPC

iSpecimen Inc

Upgrade your Finviz experience